Dental Membrane and Bone Graft Substitutes Market Size Report, 2022-2030
According to Nova one advisor, the global Dental Membrane and Bone Graft Substitutes market was valued at USD 617.3 million in 2021 and it is expected to hit around USD 1.9 billion by 2030 with a CAGR of 7.12% during the forecast period 2022 to 2030.
The dental membrane & bone graft substitutes market is driven by the rise in number of patients with dental & oral issues and growth in need for dental procedures. Dental membrane & bone graft replacements are used in bone transplant procedures. Bone transplant surgery is necessary when a tooth is lost due to an accident, dental condition, or advanced age. Bone grafts in dentistry help replace the missing bone and act as a filler for new bone growth. Substitutes for dental bone grafts are regularly used in implant treatments that call for extra bone support. Dental membranes are put above bone grafts used for dental implants rather than under the gum line. High healthcare burden caused by dental disorders is projected to propel the demand for dental membrane & bone graft replacements in the next few years.
Report Scope of the Dental Membrane and Bone Graft Substitutes Market
|
Report Coverage |
Details |
|
Market Size |
USD 1.9 Billion by 2030 |
|
Growth Rate |
CAGR of 7.12% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product, Material, End-user, and Region, |
|
Companies Mentioned |
|
High Incidence of Periodontal Disorders to Propel Demand for Dental Membrane & Bone Graft Substitute Procedures
Periodontal diseases, tooth loss, and decay are the most prevalent dental conditions. Increase in incidence of periodontal diseases is a major factor driving the demand for dental procedures. This, in turn, is fueling the demand for dental membrane & bone transplant alternatives across the world. The gums, the periodontal ligament, and the alveolar bone around the teeth are all affected by periodontal disorders. Periodontal disease is a significant risk factor for tooth loss in older adults. Leading dental membrane and bone graft substitutes companies are focusing on developing innovative periodontal equipment that can be used in dental procedures. The market for dental bone graft materials and dental membrane & soft tissue regeneration products is likely to grow in the next few years due to high incidence of periodontal defects and dental bone diseases across the globe.
Increase in Number of Dental Implant Procedures to Drive Global Market
Implant dentistry is considered quite appealing, and people across the world have a strong desire for implants. Majority of dental implant treatments employ dental bone transplant materials. Therefore, increase in dental implant procedures is expected to lead to a rise in the number of bone graft replacement procedures for the insertion and support of dental implants. Growth in number of dental implant treatments can be ascribed to the surge in incidence of oral disorders and injuries. For instance, large number of people in the U.S. and Germany who are 65 or older are edentulous. This is likely to boost the demand for dental implants in these countries during the forecast period.
Extensive Usage of Dental Bone Graft Materials to Stabilize and Support Dental Bone Regeneration
In terms of product, the global dental membrane & bone graft substitutes market has been bifurcated into dental membrane and dental bone graft. The dental membrane segment has been divided into resorbable and non-resorbable. The dental bone grafts segment has been classified into autograft, allograft, demineralized bone matrix, xenograft, and synthetic bone graft substitutes. Increase in usage of bone graft materials to stabilize and support dental bone regeneration is expected to boost the demand for these products. The allograft sub-segment led the dental bone graft segment in 2021. The xenograft sub-segment, on the other hand, is expected to grow at a rapid pace throughout the forecast period. This can be ascribed to xenograft being a less costly allograft that does not prolong healing time and eliminates the requirement for a second surgical site for bone harvesting.
Growth in Application of Human Cell Sources in Bone Graft Substitutes
Based on material, the global dental membrane & bone graft substitutes market has been segregated into hydrogel, collagen, polytetrafluoroethylene (PTFE), human cell sources, hydroxyapatite (HA), tricalcium phosphate (TCA), and others. The human cell sources segment dominated the global market in 2021. This trend is expected to continue during the forecast period. Increase in usage of human cell sources in allograft and xenograft of bone graft substitutes as well as resorbable membrane of dental membranes contributes to the growth of the segment.
Availability and Convenience Boosting Preference for Dental Clinics
In terms of end-user, the global dental membrane & bone graft substitutes market has been classified into hospitals, dental clinics, and ambulatory surgical centers. The dental clinics segment has been split into individual practice and group practice. Increase in number of geriatric patients and rise in number of dental problems or implant procedures are leading to a surge in number of bone graft procedures across the globe. Dental clinics are preferred by patients for the treatment of various minor tooth illnesses owing to their availability and convenience. The number of dental clinics is rapidly increasing across the globe. This is expected to drive the dental clinics segment in the near future.
Regional Outlook of Global Dental Membrane & Bone Graft Substitutes Market
Europe dominated the global dental membrane & bone graft substitutes market in 2021. This growth can be ascribed to the rise in prevalence of dental issues among the people, presence of well-established market players, and surge in demand for dental implants in Europe. North America accounted for the second largest share of the global market in 2021. Increase in geriatric population and rise in prevalence of dental diseases are the major factors driving the market in North America. Increase in geriatric population with missing teeth, rise in penetration of dental implants, surge in training regarding the benefits of bone graft substitutes, and growth in application of bone graft substitutes for the treatment of dental disorders are augmenting the market in Asia Pacific. Furthermore, Japan is one of the key suppliers of dental biomaterials to various countries (including India). This is propelling the market in the country.
Key Developments in Global Dental Membrane & Bone Graft Substitutes Market
Some of the prominent players in the Dental Membrane and Bone Graft Substitutes Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Dental Membrane and Bone Graft Substitutes market
By Geography
Key Benefits for Stakeholders
Chapter 1. Introduction
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dental Membrane & Bone Graft Substitutes Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, 2017–2030
4.4.1. Market Revenue Projections
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Technological Advancements
5.3. Key Mergers & Acquisitions
5.4. Covid-19 Impact Analysis
6. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2030
6.3.1. Dental Membrane
6.3.1.1. Resorbable
6.3.1.2. Non-resorbable
6.3.2. Dental Bone Graft
6.3.2.1. Autograft
6.3.2.2. Allograft
6.3.2.3. Demineralized Bone Matrix
6.3.2.4. Xenograft
6.3.2.5. Xenograft
6.4. Market Attractiveness Analysis, by Product
7. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by Material
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Material, 2017–2030
7.3.1. Hydrogel
7.3.2. Collagen
7.3.3. Polytetrafluoroethylene (PTFE)
7.3.4. Human Cells Sources
7.3.5. Hydroxyapatite (HA)
7.3.6. Tricalcium Phosphate (TCP)
7.3.7. Other Species
7.4. Market Attractiveness Analysis, by Material
8. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by End-use
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-use, 2017–2030
8.3.1. Hospitals
8.3.2. Dental Clinics
8.3.2.1. Individual Practice
8.3.2.2. Group Practice
8.3.3. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis, by End-use
9. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2030
10.2.1. Dental Membrane
10.2.1.1. Resorbable
10.2.1.2. Non-resorbable
10.2.2. Dental Bone Graft
10.2.2.1. Autograft
10.2.2.2. Allograft
10.2.2.3. Demineralized Bone Matrix
10.2.2.4. Xenograft
10.2.2.5. Xenograft
10.3. Market Value Forecast, by Material, 2017–2030
10.3.1. Hydrogel
10.3.2. Collagen
10.3.3. Polytetrafluoroethylene (PTFE)
10.3.4. Human Cells Sources
10.3.5. Hydroxyapatite (HA)
10.3.6. Tricalcium Phosphate (TCP)
10.3.7. Other Species
10.4. Market Value Forecast, by End-use, 2017–2030
10.4.1. Hospitals
10.4.2. Dental Clinics
10.4.2.1. Individual Practice
10.4.2.2. Group Practice
10.4.3. Ambulatory Surgical Centers
10.5. Market Value Forecast, by Country, 2017–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis, Analysis
10.6.1. By Product
10.6.2. By Material
10.6.3. By End-use
10.6.4. By Country
11. Europe Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2030
11.2.1. Dental Membrane
11.2.1.1. Resorbable
11.2.1.2. Non-resorbable
11.2.2. Dental Bone Graft
11.2.2.1. Autograft
11.2.2.2. Allograft
11.2.2.3. Demineralized Bone Matrix
11.2.2.4. Xenograft
11.2.2.5. Xenograft
11.3. Market Value Forecast, by Material, 2017–2030
11.3.1. Hydrogel
11.3.2. Collagen
11.3.3. Polytetrafluoroethylene (PTFE)
11.3.4. Human Cells Sources
11.3.5. Hydroxyapatite (HA)
11.3.6. Tricalcium Phosphate (TCP)
11.3.7. Other Species
11.4. Market Value Forecast, by End-use, 2017–2030
11.4.1. Hospitals
11.4.2. Dental Clinics
11.4.2.1. Individual Practice
11.4.2.2. Group Practice
11.4.3. Ambulatory Surgical Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis, Analysis
11.6.1. By Product
11.6.2. By Material
11.6.3. By End-use
11.6.4. By Country/Sub-region
12. Asia Pacific Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2030
12.2.1. Dental Membrane
12.2.1.1. Resorbable
12.2.1.2. Non-resorbable
12.2.2. Dental Bone Graft
12.2.2.1. Autograft
12.2.2.2. Allograft
12.2.2.3. Demineralized Bone Matrix
12.2.2.4. Xenograft
12.2.2.5. Xenograft
12.3. Market Value Forecast, by Material, 2017–2030
12.3.1. Hydrogel
12.3.2. Collagen
12.3.3. Polytetrafluoroethylene (PTFE)
12.3.4. Human Cells Sources
12.3.5. Hydroxyapatite (HA)
12.3.6. Tricalcium Phosphate (TCP)
12.3.7. Other Species
12.4. Market Value Forecast, by End-use, 2017–2030
12.4.1. Hospitals
12.4.2. Dental Clinics
12.4.2.1. Individual Practice
12.4.2.2. Group Practice
12.4.3. Ambulatory Surgical Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017–2030
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis, Analysis
12.6.1. By Product
12.6.2. By Material
12.6.3. By End-use
12.6.4. By Country/Sub-region
13. Latin America Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2030
13.2.1. Dental Membrane
13.2.1.1. Resorbable
13.2.1.2. Non-resorbable
13.2.2. Dental Bone Graft
13.2.2.1. Autograft
13.2.2.2. Allograft
13.2.2.3. Demineralized Bone Matrix
13.2.2.4. Xenograft
13.2.2.5. Xenograft
13.3. Market Value Forecast, by Material, 2017–2030
13.3.1. Hydrogel
13.3.2. Collagen
13.3.3. Polytetrafluoroethylene (PTFE)
13.3.4. Human Cells Sources
13.3.5. Hydroxyapatite (HA)
13.3.6. Tricalcium Phosphate (TCP)
13.3.7. Other Species
13.4. Market Value Forecast, by End-use, 2017–2030
13.4.1. Hospitals
13.4.2. Dental Clinics
13.4.2.1. Individual Practice
13.4.2.2. Group Practice
13.4.3. Ambulatory Surgical Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017–2030
13.5.1. Mexico
13.5.2. Brazil
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis, Analysis
13.6.1. By Product
13.6.2. By Material
13.6.3. By End-use
13.6.4. By Country/Sub-region
14. Middle East & Africa Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2030
14.2.1. Dental Membrane
14.2.1.1. Resorbable
14.2.1.2. Non-resorbable
14.2.2. Dental Bone Graft
14.2.2.1. Autograft
14.2.2.2. Allograft
14.2.2.3. Demineralized Bone Matrix
14.2.2.4. Xenograft
14.2.2.5. Xenograft
14.3. Market Value Forecast, by Material, 2017–2030
14.3.1. Hydrogel
14.3.2. Collagen
14.3.3. Polytetrafluoroethylene (PTFE)
14.3.4. Human Cells Sources
14.3.5. Hydroxyapatite (HA)
14.3.6. Tricalcium Phosphate (TCP)
14.3.7. Other Species
14.4. Market Value Forecast, by End-use, 2017–2030
14.4.1. Hospitals
14.4.2. Dental Clinics
14.4.2.1. Individual Practice
14.4.2.2. Group Practice
14.4.3. Ambulatory Surgical Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017–2030
14.5.1. South Africa
14.5.2. GCC countries
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis, Analysis
14.6.1. By Product
14.6.2. By Material
14.6.3. By End-use
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Institut Straumann AG
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. BioHorizons
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Collagen Matrix, Inc.
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Dentsply Sirona
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Geistlich Pharma AG
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Nobel Biocare Services AG
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. NovaBone Products, LLC.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. OPKO Health, Inc.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. Zimmer Biomet
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers